| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |